Characterization of the catalytic subunit of factor XIII by radioimmunoassay

Blood. 1982 Nov;60(5):1089-95.

Abstract

Plasma factor XIII is composed of two subunits, a and b, whereas platelet and other intracellular zymogens have only a-subunits. The catalytic subunit, a, is the same in all forms. In order to characterize the interactions of 1- with b-chains in the plasma zymogen and a-chains with other molecules and to correlate factor XIII activity with a-protein, a specific, sensitive radioimmunoassay was developed. With the polyclonal antisera used, the assay recognizes all molecular forms of a (zymogens, activation intermediates, enzyme) equally well. The assay can be used to determine a-chain concentration in plasma and serum and in purified test systems. Fibrinogen in high concentrations affects the assay, probably by interfering with the interactions of 125I-a with antibody. However, at the plasma dilutions used in the assay, there is no significant fibrinogen effect. With this assay, the a-chain concentration in normal plasma is approximately 15 micrograms/ml. This compares with 14 micrograms/ml b-chain in plasma and indicates that all of the a- and b-chains in plasma probably circulate in the form of an equimolar zymogen complex. The serum concentration of a-protein is about 6% of the plasma concentration. There is a high correlation between a-protein and factor XIII activity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Factor XIII / analysis*
  • Fibrin Fibrinogen Degradation Products
  • Humans
  • Peptides / analysis
  • Peptides / immunology
  • Radioimmunoassay

Substances

  • Fibrin Fibrinogen Degradation Products
  • Peptides
  • Factor XIII